-
Editor's Letter
Cancer Research: Worth Paying ForKevin McLaughlin discusses how one survivor's faith in science underscores the importance of continued funding for cancer research.
by Kevin McLaughlin
-
Forward Look
Truth in AdvertisingSeveral countries explore legality of requiring cigarettes to carry graphic pictures and health warnings.
by Sue Rochman
-
Forward Look
Coming Up ShortA limited supply of cancer medications is affecting care.
by Steve McIver
-
Survivor Profile
Betting on ScienceDiagnosed with a rare and incurable blood cancer, Jack Whelan is a passionate booster for research, clinical trials and affordable treatments.
by Betty Russell
-
Get Involved
Sending Get Well WishesJoan A. Smith organizes volunteers' efforts to send cards to cancer patients.
by Maria Wolf
-
More Than a Signature
The informed consent process is designed to ensure that patients understand risks. But new advances involved in genetic testing and tissue donation may make signing on the dotted line more complex than ever.
by Stephen Ornes
-
Editor's Letter
Making PlansA cancer diagnosis can quickly change your “other plans.”
by Kevin McLaughlin
-
Forward Look
When the Cancer Doctor Gets CancerQ & A with breast surgeon Susan Love on her new role: cancer survivor.
by Betty Russell
-
Forward Look
Paying a Steep PriceNew laws are pushing health insurers to make oral cancer drugs affordable.
by Betty Russell
-
Forward Look
This Way to the Quit LineDoctors and researchers are encouraged to talk to patients about tobacco use.
by Sue Rochman
Cancer Talk
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood Tests
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles